A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism.
Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, Jiang M, Zhou Y, Barve S, Zhang X, McClain CJ, Feng W.
Hepatology. 2020 Jun;71(6):2050-2066. doi: 10.1002/hep.30975. Epub 2020 Mar 16.
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.
Sutton H, Karpen SJ, Kamath BM.
Annu Rev Pathol. 2024 Jan 24;19:319-344. doi: 10.1146/annurev-pathmechdis-031521-025623.
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Paumgartner G, Beuers U.
Clin Liver Dis. 2004 Feb;8(1):67-81, vi. doi: 10.1016/S1089-3261(03)00135-1.
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
Danielsson O, Vesterinen T, Arola J, Åberg F, Nissinen MJ.
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):961-969. doi: 10.1097/MEG.0000000000002785. Epub 2024 Apr 26.
Recent advances in the management of pediatric cholestatic liver diseases.
Mysore KR, Cheng K, Suri LA, Fawaz R, Mavis AM, Kogan-Liberman D, Mohammad S, Taylor SA.
J Pediatr Gastroenterol Nutr. 2025 Apr;80(4):549-558. doi: 10.1002/jpn3.12462. Epub 2025 Jan 22.
A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism.
She HY, Qiu YL, Feng JY, Cheng Y, Chi H, van IJzendoorn SCD, Xing QH, Wang JS.
Biochem Biophys Res Commun. 2025 Apr 12;758:151669. doi: 10.1016/j.bbrc.2025.151669. Epub 2025 Mar 20.
Drug-induced hepatotoxicity.
Kaplowitz N, Aw TY, Simon FR, Stolz A.
Ann Intern Med. 1986 Jun;104(6):826-39. doi: 10.7326/0003-4819-104-6-826.
Fibrates and cholestasis.
Ghonem NS, Assis DN, Boyer JL.
Hepatology. 2015 Aug;62(2):635-43. doi: 10.1002/hep.27744. Epub 2015 Mar 23.
Changes in Protein Metabolism and Early Development of Sarcopenia in Mice With Cholestatic Liver Disease.
Agrifoglio O, Görs S, Sciascia Q, Li Z, Albrecht E, Achilles S, Statz M, Bastian M, Lindner T, Gauß KF, Rohde S, Rischmüller K, Berlin P, Lamprecht G, Jaster R, Metges CC, Ehlers L.
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13737. doi: 10.1002/jcsm.13737.
Methylcobalamin protects against liver failure via engaging gasdermin E.
Xu W, Wang Y, Cui S, Zheng Q, Lin Y, Cui Q, Xie Y, Zeng Y, Zhang C, Li Y, Jin X, Qin M, Sun H, Hao H, Cao L.
Nat Commun. 2025 Jan 31;16(1):1233. doi: 10.1038/s41467-024-54826-6.
